Trial intelligence / Profile preview

CAMFIB: Indocyanine Green vs Methylene Blue in Hepatectomy

NCT01847612Phase 3Completed

Sponsor
CHU Amiens-Picardie
Start
Jul 2013
Primary completion
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of indocyanine green in liver disease, sponsored by CHU Amiens-Picardie. Started Jul 2013; status: completed.

02

Drugs

indocyanine green
03

Conditions

liver disease

Beyond the preview

Go deeper on NCT01847612.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01847612.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call